EN
Türkçe
Deutsch
Français
Español
Português
Русский
العربية
中文
日本語
iShares Biotechnology ETF (IBB)
iShares Biotechnology ETF last traded at 212.20 USD. Over the past month the price moved +0.71%. Historical scenarios, expert targets and the plain-language read from AIsier.
One-year price chart
Last price
212.20 USD
- 1 week
- +0.81%
- 1 month
- +0.71%
- 3 months
- +12.56%
- 1 year
- +35.34%
- 52-week high
- 216.95 USD
- 52-week low
- 155.77 USD
Funds
- Symbol
- IBB
- Currency
- USD
- Exchange
- NYSE
AIsier's plain-language read
IBB has climbed roughly 25% this year, its strongest run in three years.
What is going on right now?
The fund rose about 3.5% in the past week, sitting above where it traded over the last several months. Trading activity has been quieter than usual, though.
How is the business itself doing?
This is a basket of biotech companies, almost entirely in healthcare. Nearly half its money sits in just ten names, with Gilead, Amgen, and Vertex each making up around 8%.
What stands out?
Novo Nordisk's upcoming obesity drug data may ripple across the whole biotech space, since many of IBB's largest holdings compete in overlapping areas.
What comes next?
That Novo Nordisk trial readout is the nearest concrete event. How the market digests those results will show up quickly in IBB's biggest holdings.
Historical scenarios that name this asset
FAQ
What is the current price of iShares Biotechnology ETF?
As of Oct. 27, 2026, the latest recorded price of iShares Biotechnology ETF (IBB) was 212.20 USD.
How has iShares Biotechnology ETF moved recently?
Measured from closing prices: +0.81% over one week, +0.71% over one month and +35.34% over one year.
Which historical scenarios name iShares Biotechnology ETF?
iShares Biotechnology ETF appears in 1 documented scenario: Drug Research & Approvals.